Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: Sentinel node vs Observation after axillary UltraSouND)

Oreste Gentilini, Umberto Veronesi

Research output: Contribution to journalArticlepeer-review

Abstract

Sentinel lymph node biopsy (SLNB) is the standard approach for axillary staging in patients with early breast cancer. Recent data showed no outcome difference in patients with positive sentinel node between axillary dissection vs no further axillary surgery, raising doubts on the role of SLNB itself. Therefore, a new trial was designed comparing SLNB vs observation when axillary ultra-sound is negative in patients with small breast cancer candidates to breast conserving surgery.

Original languageEnglish
Pages (from-to)678-681
Number of pages4
JournalBreast
Volume21
Issue number5
DOIs
Publication statusPublished - Oct 2012

Keywords

  • Axillary surgery
  • Breast cancer treatment
  • Sentinel lymph node biopsy (SLNB)
  • Ultra-sound

ASJC Scopus subject areas

  • Surgery

Fingerprint Dive into the research topics of 'Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: Sentinel node vs Observation after axillary UltraSouND)'. Together they form a unique fingerprint.

Cite this